Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
BLISSGVS | NSE
13.81
6.41%
Healthcare
Drug Manufacturers-Specialty & Generic
31/03/2024
01/04/2026
229.40
228.00
233.80
221.87
Bliss GVS Pharma Limited develops manufactures and markets pharmaceutical formulations in India. It offers pharma products including capsules creams/gels/ointments dry powder for injections and oral suspensions effervescent tablets eye/ear drops injections liquid preparations lotions lozenges nasal solutions oral solids parenterals pessaries sachets soft gelatin capsules suppositories suspensions syrups tablets topical preparations and transdermal patches. The company provides other healthcare products such as balms creams lotions lozenges nasal inhalers over the counter products petroleum jellies powders roll-ons shampoos soaps solutions sprays syrups and vaginal washes. In addition it offers therapeutic products consisting of anti-bacterial anti-dandruff shampoo amino acid preparation iron tonic antitussive appetite stimulant anti-allergic body supplement anti-biotic anti-diabetic anti-diarrheal anti-emetic anti-fungal anti-haemorrhoidal anti-helmintic anti-infective anti-inflammatory anti-malarial anti-microbial anti-migraine anti-oxidant anti-protozoal ear wax solvent anti-pyretic anti-septic anti-spasmodic anti-ulcer and anti-ulcerant; and analgesic oral rehydration antacid anxiolytic appetizer cough syrup erectile dysfunction haematinic hand sanitizer health supplement insecticide laryngitis pharyngitis laxative lubricant mosquito repellant nasal decongestant nutritional supplement moisturizer prickly heat powder skin lightening lotion vaginal contraceptive vaginal hygiene and vitamin supplements as well as soaps. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai India.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
92.0%1 month
73.8%3 months
67.8%6 months
67.8%17.04
-
1.51
0.10
0.08
8.99
1.80
-
1.59B
24.16B
259.23M
0.38
14.97
39.90
15.10
8.50
-
-
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
40.73
Range1M
40.73
Range3M
91.64
Rel. volume
1.62
Price X volume
691.94M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Orchid Pharma Limited | ORCHPHARMA | Drug Manufacturers-Specialty & Generic | 519.3 | 26.44B | 7.64% | 59.92 | 11.56% |
| Dishman Carbogen Amcis Limited | DCAL | Biotechnology | 146.14 | 22.91B | 12.44% | n/a | 41.09% |
| Unichem Laboratories Limited | UNICHEMLAB | Drug Manufacturers-Specialty & Generic | 298.2 | 21.07B | 1.62% | n/a | 10.48% |
| Morepen Laboratories Limited | MOREPENLAB | Drug Manufacturers-Specialty & Generic | 37.2 | 20.55B | 10.45% | 37.53 | 3.42% |
| Panacea Biotec Limited | PANACEABIO | Biotechnology | 325.3 | 20.30B | 9.88% | n/a | 2.49% |
| SOLARA | SOLARA | Drug Manufacturers-Specialty & Generic | 459.1 | 19.89B | 7.88% | n/a | 107.90% |
| Hikal Limited | HIKAL | Drug Manufacturers-Specialty & Generic | 159.96 | 19.72B | 8.76% | 69.03 | 68.84% |
| Alembic Limited | ALEMBICLTD | Drug Manufacturers-Specialty & Generic | 76.49 | 19.71B | 7.88% | 12.29 | 0.42% |
| Indoco Remedies Limited | INDOCO | Drug Manufacturers-Specialty & Generic | 187.08 | 17.24B | 14.07% | 42.22 | 60.54% |
| Windlas Biotech Limited | WINDLAS | Drug Manufacturers-Specialty & Generic | 767.65 | 16.10B | 4.19% | 35.85 | 0.81% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| "SAI SILKS (KALAMANDIR) LIMITED " | KALAMANDIR | Apparel Retail | 101.34 | 14.93B | 12.25% | 28.83 | 43.67% |
| Signpost India Limited | SIGNPOST | Advertising Agencies | 231.11 | 13.55B | 4.36% | 30.54 | 80.30% |
| V2 Retail Limited | V2RETAIL | Apparel Retail | 189.42 | 6.76B | 0.17% | 120.49 | 191.28% |
| Bhagyanagar India Ltd | BHAGYANGR | Copper | 151.06 | 4.88B | 9.69% | 36.36 | 52.08% |
| Madhav Copper Limited | MCL | Copper | 57.49 | 1.59B | 4.99% | 82.22 | 32.14% |
| Cubex Tubings Limited | CUBEXTUB | Copper | 83.8 | 1.22B | 13.34% | 35.85 | 21.78% |
| Touchwood Entertainment Limited | TOUCHWOOD | Advertising Agencies | 65.89 | 734.59M | 4.50% | 50.06 | 4.88% |
| Sagardeep Alloys Limited | SAGARDEEP | Copper | 22.89 | 397.37M | 3.95% | 58.62 | 43.14% |
| Heads UP Ventures Limited | HEADSUP | Apparel Retail | 6.92 | 151.62M | 14.38% | n/a | 0.00% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 8.99 | 24.85 | Cheaper |
| Ent. to Revenue | 1.80 | 11.40 | Cheaper |
| PE Ratio | 17.04 | 51.36 | Cheaper |
| Price to Book | 1.51 | 6.83 | Cheaper |
| Dividend Yield | 0.38 | 0.52 | Poor |
| Std. Deviation (3M) | 67.80 | 42.17 | Riskier |
| Debt to Equity | 0.10 | 0.35 | Cheaper |
| Debt to Assets | 0.08 | 0.17 | Cheaper |
| Market Cap | 24.16B | 290.82B | Emerging |